Develops and markets implants and instruments for spinal surgery

Implanet S.A.

Martillac (France) · Memphis, TN (USA) · Boston, MA (USA)New on Amplifa

46Employees

12,5 Mio. € (2025)Revenue

42Countries with presence

18 JahreExperience in spinal implants

About Implanet

Implanet is a publicly listed medical technology company headquartered in Martillac near Bordeaux (France), specializing in products for spinal surgery. The portfolio includes implants from the Jazz™, Zeus™, Saxxo™, Swingo™, Squale™ and Origin™ brands as well as the Olea™ ultrasonic osteotome. The flagship product Jazz™ is protected by four international patent families and bears the CE mark as well as FDA 510(k) clearance. Development takes place in close collaboration between spine surgeons, engineers and product managers based on scientifically and clinically validated designs. Quality assurance is ensured through a triple quality control system (in production, at final release and at headquarters), individual sterile packaging and peelable traceability labels. With 46 employees, revenue of €12.5 million (2025) and its US subsidiary Implanet America (Memphis), the company is represented in 42 countries.

Site: Martillac
Processes: R&D and development of spinal implants, Triple quality control (in production, final release inspection, inspection at headquarters), Individual sterile packaging, Traceability (peelable labels), Distribution via subsidiary Implanet America
Materials: ISO and ASTM standards
Certificates: CE marking (Regulation (EU) 2017/745 or Directive 93/42/EEC), FDA 510(k), ANVISA approval (Brazil), CE marking (EU 2017/745 or 93/42/EEC), ANVISA (Brazil), ISO/ASTM standards
Employees: 46
Industries: Medical technology, Orthopedics, Spinal surgery

01
R&D and product development with surgeons and engineers
02
Manufacturing by partner producers with ongoing quality control
03
Final release inspection
04
Third quality control system in the specialized unit at headquarters
05
Individual sterile packaging
06
Distribution via subsidiary Implanet America and international partners

Materials and Standards

ISO/ASTM

ISO and ASTM standards

All products are tested according to the applicable ISO and ASTM standards.

Locations

Martillac

Headquarters (Technopole Montesquieu, allée François Magendie) with quality control unit

Memphis, TN

Implanet America, US sales (1661 International Drive, Suite 400)

Boston, MA

US subsidiary near Boston

Products

**Jazz™ – spinal fixation system**Implants · Spinal surgery

**Olea™ – Ultrasonic osteotome**Medical device · Spinal surgery

Inside the production

Industries

Medical technologyOrthopedicsSpinal surgery

Additional services

R&D and development of spinal implantsTriple quality control (in production, final release inspection, inspection at headquarters)Individual sterile packagingTraceability (peelable labels)Distribution via subsidiary Implanet America

Quality and Certification

Implanet applies a triple quality control system: a first inspection in production, a second inspection at final release and a third inspection in the specialized unit at headquarters. The products meet the applicable ISO and ASTM standards, the requirements of EU Directive 93/42/EEC or the MDR (CE marking), FDA 510(k) and the Brazilian ANVISA.

Evidence	Martillac
CE marking (EU 2017/745 or 93/42/EEC)
FDA 510(k)
ANVISA (Brazil)
ISO/ASTM standards

History

18 years of experience in spinal implants